Irland -
Englisch -
HPRA (Health Products Regulatory Authority)
nolvadex d 20 mg film-coated tablets
astrazeneca ab - tamoxifen - film-coated tablet - 20 milligram(s) - anti-estrogens; tamoxifen
Malta -
Englisch -
Malta Medicines Authority
nolvadex d 20mg film-coated tablets
astrazeneca ab se-151 85, södertälje, sweden - tamoxifen citrate - film-coated tablet - tamoxifen citrate 20 mg - endocrine therapy
Malta -
Englisch -
Malta Medicines Authority
letroblock 2.5 mg film-coated tablets
focused pharma ltd 37, geronimo abos street, iklin ikl 1022, malta - letrozole - film-coated tablet - letrozole 2.5 mg - endocrine therapy
Malta -
Englisch -
Malta Medicines Authority
lapatinib pharos 250 mg film-coated tablets
pharos – pharmaceutical oriented services limited lesvou str. (end), thesi loggos, industrial zone, 144 52 metamorfossi attikis,, greece - film-coated tablet - lapatinib 250 mg - antineoplastic agents
Irland -
Englisch -
HPRA (Health Products Regulatory Authority)
letrozole
accord healthcare limited - letrozole - film coated tablet - 2.5 milligram - letrozole
Irland -
Englisch -
HPRA (Health Products Regulatory Authority)
letrozole film coated tablet 2.5 milligram
flynn pharma ltd - letrozole - film coated tablet - 2.5 milligram
Irland -
Englisch -
HPRA (Health Products Regulatory Authority)
letrozole film coated tablet 2.5 milligram
caduceus pharma ltd - letrozole - film coated tablet - 2.5 milligram
Irland -
Englisch -
HPRA (Health Products Regulatory Authority)
letrozole
fresenius kabi oncology plc - letrozole - film coated tablet - 2.5 milligram - letrozole
Australien -
Englisch -
Department of Health (Therapeutic Goods Administration)
apo-letrozole letrozole 2.5mg tablet bottle
arrotex pharmaceuticals pty ltd - letrozole, quantity: 2.5 mg - tablet, film coated - excipient ingredients: microcrystalline cellulose; macrogol 8000; lactose monohydrate; iron oxide yellow; hyprolose; titanium dioxide; sodium starch glycollate; magnesium stearate; hypromellose - ? treatment of postmenopausal women with hormone receptor positive early breast cancer (see clinical trials). ? the safety and efficacy of neoadjuvant use of letrozole has not been established. letrozole is not indicated in hormone receptor negative disease.
Singapur -
Englisch -
HSA (Health Sciences Authority)
letrovitae film-coated tablets 2.5mg
united italian trading corporation (private) limited - letrozole - tablet, film coated - letrozole 2.50mg